F. Beil

Cerebrovascular atherosclerosis in type III hyperlipidemia is modulated by variation in the Apolipoprotein A5 gene

D. Evans, A. Bode, G. von der Lippe, 2011, European journal of medical research.

The single nucleotide polymorphism −1131T>C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia

D. Evans, F. Beil, A. Buchwald, 2003, Journal of Molecular Medicine.

A polymorphism in the apolipoprotein A5 gene is associated with weight loss after short‐term diet

U. Seedorf, J. Aberle, D. Evans, 2005, Clinical genetics.

Resequencing the apolipoprotein A5 (APOA5) gene in patients with various forms of hypertriglyceridemia.

J. Aberle, D. Evans, F. Beil, 2011, Atherosclerosis.

Rare variants in the lipoprotein lipase (LPL) gene are common in hypertriglyceridemia but rare in Type III hyperlipidemia.

J. Aberle, D. Evans, F. Beil, 2011, Atherosclerosis.

Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia

U. Seedorf, D. Evans, F. Beil, 2005, Clinical genetics.

Apolipoprotein C‐ll deficiency syndrome due to apo C‐IIHamburg: clinical and biochemical features and Hphl restriction enzyme polymorphism

H. Brewer, U. Beisiegel, F. Beil, 1992, European journal of clinical investigation.